12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

GenomEra Clostridium difficile assay regulatory update

Abacus received CE Mark approval for its GenomEra Clostridium difficile assay to detect toxin-producing Clostridium difficile...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >